Bklyn CBD LEMON DOWN TIME DROPS - 3000MG
Bklyn CBD LEMON DOWN TIME DROPS - 3000MG
BKLYN CBD Lemon Down Time Drops are naturally flavored with organic citrus extracts. They are great to unwind from the ups and downs of everyday life. Take it down a notch with this tincture*. Made from organic U.S. grown hemp, our drops contains all of the plant's terpenes and cannabinoids to provide a full spectrum blend.
Shake well. Take the oil sublingually and swallow. One dropper delivers about 100mg of CBD. Take additional droppers for the unwinding effect you desire.
100mg CBD / 1ml
30ml bottle with 3000mg of CBD Oil
Non-psychoactive CBD made from organic U.S. hemp
Flavored with organic lemon extract
All natural, contains no artificial flavors or coloring
Vegan, gluten free, alcohol free and sugar free
Need to know: If you don't feel anything at first, be patient. Just like when you start taking a new supplement or regimen, it takes time to feel the full effects. Stay consistent. The results are cumulative and oftentimes subtle at first.
Ingredients: Whole plant hemp extract (CBD), MCT oil (fractionated coconut oil), natural raw hemp oil, organic sunflower lecithin, organic lemon extract.
Suggested Dosage: Start small with 1/2 dropper. It's generally recommended to start small and work your way up.
If your employment requires a drug test, please talk to your employer or physician first. Contains less than 0.3% THC.
Keep out of reach of children. Consult your doctor before taking if you are pregnant or nursing, have a medical condition, or take pharmaceutical drugs.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Why CBD ?
CBD THERAPEUTIC BENEFITS
The World Health Organization published a report on CBD in November of 2017. Below is an overview in which CBD may have therapeutic benefits.
Disease
Effects
Alzheimer's disease
Antinflammatory, antioxidant, antiapoptotic in in vitro and in vivo models
of Aβ-evoked neuroinflammatory and neurodegenerative responses.
Parkinson's disease
Attenuation of the dopaminergic impairment in vivo; neuroprotection; improvement of psychiatric rating and reduction of agitation, nightmare
and aggressive behaviour in patients.
Multiple sclerosis
Improved signs of EAE in mice, antinflammatory and immunomodulatory
properties.
Huntington's
disease
Neuroprotective and antioxidant in mice transgenic models; no significant
clinically important differences in patients.
Hypoxia-ischemia
injury
Short term neuroprotective effects; inhibition of excitotoxicity, oxidative
stress and inflammation in vitro and in rodent models.
Pain
Analgesic effect in patients with neuropathic pain resistant to other
treatments.
Psychosis
Attenuation of the behavioural and glial changes in animal models of
schizophrenia; anti-psychotic properties on ketamine-induced symptoms
Anxiety
Reduction of muscular tension, restlessness, fatigue, problems in concentration, improvement of social interactions in rodent models of
anxiety and stress; reduced social anxiety in patients.
Depression
Anti-depressant effect in genetic rodent model of depression.
Cancer
Antiproliferative and anti-invasive actions in a large range of cancer types;
induction of autophagy-mediated cancer cell death; chemopreventive effects.
Nausea
Suppression of nausea and conditioned gaping in rats
Inflammatory
diseases
Antinflammatory properties in several in vitro and in vivo models;
inhibition of inflammatory cytokines and pathways.
Rheumatoid
arthritis
Inhibition of TNF-α in an animal model
Infection
Activity against methicillin-resistant Staphylococcus aureus
Inflammatory bowel and Crohn's
diseases
Inhibition of macrophage recruitment and TNF-α secretion in vivo and ex vivo; reduction in disease activity index in Crohn's patients.
Cardiovascular
diseases
Reduced infarct size through anti-oxidant and anti-inflammatory
properties in vitro and in vivo.
Diabetic
complications
Attenuation of fibrosis and myocardial dysfunction